데일리팜 vs 한국일보.
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
데일리팜
This is a specialized online news source focusing on the pharmaceutical and bio-industry, as well as pharmacies and hospitals. It provides dedicated news coverage and resources for professionals in these sectors.
- Pharmaceutical and bio industry news
- Pharmacy and hospital industry news
- Job recruitment for the industry
- Industry-specific real estate listings
- Community forums for professionals
Read full descriptionHide full description
대한민국 1위 의약전문 인터넷 신문 데일리팜은 국내 첫 의약전문 인터넷 언론사로 1999년 6월 오픈하였습니다. 제약·바이오, 약국·병원 산업에 특화된 전문언론사입니다. ■ 제공 서비스 - 제약뉴스 - 팜리쿠르트 - 팜아카데미 - DP부동산 - 데일리팜맵 - 팜스타클럽 - 커뮤니티 약담소 앱 사용 중에 궁금하신 점 또는 문제가 발생할 경우, admin@dailypharm.com으로 연락 주시기 바랍니다
한국일보.
This newspaper app delivers news and information with a commitment to trust and communication. It continuously innovates to uphold its founding principles of impartiality.
- Impartial news reporting
- Commitment to trust
- Continuous innovation
- Focus on communication
- Young newspaper spirit
Read full descriptionHide full description
한국일보는 불편부당의 창간 정신 위에서 ‘신뢰와 소통’이라는 언론의 본질적인 존재가치를 구현하기 위해 끊임없이 변화와 혁신을 시도해 온 젊은 신문 입니다.
Screenshots
Verdict
The clearest difference is ads: 데일리팜 at none against 한국일보.'s shown. 데일리팜 also leads on monetization model (free vs ad-supported). 한국일보.'s advantage is update cadence (fortnightly vs every 11 months). On price, review sentiment, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
데일리팜 ships an update every 11 months, 한국일보. fortnightly. Both last shipped on October 29, 2026.
| Parameter | 데일리팜 | 한국일보. |
|---|---|---|
| Price | Free | Free |
| Rating | — | 4.4 (7 ratings) — better |
| Positive reviews | 40.0% of reviews — better | 33.3% of reviews |
| Number of ratings | — | 7 — better |
| Update frequency | Every 11 months | Fortnightly — better |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Free — better | Ad-supported |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 16.0 | 15.1 — better |
| Further details — not scored | ||
| Size | 1 MB | 68 MB |
| Age rating | 4+ | 4+ |
| Developer | 데일리팜 | The Hankookilbo |
Customer experience
데일리팜
한국일보.
In-app purchases
데일리팜
No in-app purchases
한국일보.
No in-app purchases
